Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
MULTIPLE MYELOMA BY THE NUMBERS MULTIPLE MYELOMA IS A PROGRESSIVE BLOOD CANCER THAT ORIGINATES IN THE BONE MARROW . IT OCCURS WHEN SPECIFIC TYPES OF WHITE BLOOD CELLS, CALLED PLASMA CELLS , BECOME CANCEROUS AND MULTIPLY UNCONTROLLABLY, OVERCROWDING THE BONE MARROW. THERE ARE A VARIETY OF RISK FACTORS FOR MULTIPLE MYELOMA: AGE IS A MOST PEOPLE PRIMARY RISK DIAGNOSED WITH FACTOR. MULTIPLE MYELOMA ARE 65+ YEARS OLD OCCURS MORE COMMONLY IN IT IMPACTS SLIGHTLY MORE MEN THAN WOMEN SOME RACIAL GROUPS, SUCH AS AFRICAN AMERICANS GLOBAL 1-YEAR PREVALENCE (PER 100,000) 3.2+ 1.0–3.2 0.44–1.0 0.15–0.44 <0.15 NO DATA 114,250+ ESTIMATED NEW CASES LESS THAN 50% 80,000+ OF PATIENTS ESTIMATED MORTALITY S URVIVE FIVE YEARS AFTER DIAGNOSIS. Source: GLOBOCAN 2012 (IARC) © 2016 Bristol-Myers Squibb Company